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1 These authors contributed equally.Wnt/b-catenin signaling plays critical roles in embryonic development and tissue homeostasis in
adults by controlling the expression of target genes. We found that expression of ptpro, which
encodes a protein tyrosine phosphatase receptor type O (PTPRO), was induced by Wnt/b-catenin sig-
naling in a T cell factor/lymphoid enhancer factor dependent manner. Biochemical assays found that
PTPRO interacted withWnt via its extracellular domain. In addition, ectopic expression of this extra-
cellular domain inhibited Wnt-mediated reporter activity. These results suggest that ptpro is a tar-
get gene of Wnt/b-catenin signaling and that PTPRO may function as a novel receptor for Wnt.
Structured summary:
MINT-7992076: Ptpro (uniprotkb:Q7TSY7) physically interacts (MI:0915) withWnt3a (uniprotkb:P27467)
by anti tag coimmunoprecipitation (MI:0007)
MINT-7992094: Ptpro (uniprotkb:Q7TSY7) physically interacts (MI:0915) withWnt-3a (uniprotkb:P27467)
by cross-linking study (MI:0030)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction Dishevelled, leading to inactivation of the b-catenin destructionWnt signaling plays pivotal roles in the regulation of cell pro-
liferation and fate determination. Mis-regulation of Wnt signaling
is known to be the pathogenesis of many human diseases and
developmental defects [1,2]. Wnts are a family of secreted glyco-
proteins that can transduce signals via regulation of its key
effector molecule, b-catenin [3]. In the absence of Wnt, cytoplas-
mic b-catenin is constitutively degraded by a destruction complex
comprising Axin, adenomatous poly coli, glycogen synthase ki-
nase 3b (GSK3b) and other proteins [4]. Under these conditions,
T cell factor/lymphoid enhancer factor (Tcf/Lef1) acts as a tran-
scriptional repressor that blocks the expression of Wnt target
genes by forming a complex with Groucho and other proteins
[5,6]. However, in the presence of Wnt, binding of Wnt to its
receptor Frizzled and co-receptor low density lipoprotein recep-
tor-related protein 5/6 leads to initiation of downstream Wnt sig-
naling. Activated receptors transduce the signal throughchemical Societies. Published by E
atase receptor type O; APC,
ase 3b; Tcf/Lef1, T cell factor/
tein receptor-related protein
tin immunoprecipitation; Fc,complex. As a result, the level of cytoplasmic b-catenin is in-
creased, and translocation to the nucleus allows b-catenin to in-
duce numerous target genes by changing Tcf/Lef1 into a
transcriptional activator [6,7]. To date, about 100 target genes
for Wnt have been identiﬁed, some of which enhance cellular pro-
liferation or regulate differentiation, etc. (http://www.stanford.
edu/~rnusse/pathways/targets.html).
Protein tyrosine phosphatase receptor type O (PTPRO) is a type
III protein tyrosine phosphatase comprising seven repetitive ﬁbro-
nectin like III (FN III) repeats in its extracellular domain (ECD), a
transmembrane domain, a juxtamembrane domain and one phos-
phatase domain in its intracellular domain (ICD) (Fig. 3A) [8].
PTPRO has been described as mPTP-BK, mGLEPP1 in mouse and
CRYP-2 in chicken [9–11]. While receptor protein tyrosine kinase
signaling has been intensively studied, the role of protein tyrosine
phosphatase, the identiﬁcation of substrates/ligands or the physio-
logical roles in signaling has not been examined so far. Several
studies indicate that PTPRO is involved in axon guidance or proper
axon projection [12]. Expression of ptpro is highest in embryonic
day 16 of mouse embryos when axonogenesis and synapse forma-
tions are most activated, and PTPRO works as a receptor to sense a
repulsive guidance cue for retinal neuron growth cones [13,14].
We tried to identify novel target genes of Wnt signaling using
microarray analysis, which compares gene expression proﬁles by
inducible expression of Dvl or b-catenin S37A (activated form oflsevier B.V. All rights reserved.
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expression of ptpro was induced by the inducible expression of Dvl
or b-catenin. Interestingly, we also discovered that PTPRO inter-
acted with Wnt ligand through its ECD, resulting in inhibition of
Wnt/b-catenin signaling. Overall, our data suggest that ptpro is a
target gene of Wnt/b-catenin signaling and that PTPRO may func-
tion as a novel receptor for Wnt.2. Materials and methods
2.1. Plasmids
Full-length mouse cDNA of PTPRO was ligated with pCS2-HA or
pCMV5 vector to make a PTPRO-HA or PTPRO-Flag construct,
respectively. To make PTPRO(ECD)-Flag or PTPRO(DEx)-Flag, PCR
products containing the region from the 50 to 30 end of the extracel-
lular domain or from the transmembrane domain to the 30 end of
the mouse PTPRO cDNA were cloned into pCMV5 vector, respec-
tively. For PTPRO-ECD(1-3)-Fc, a PCR product containing the region
from the 50 end to the third FN III repeats of the extracellular do-
main was cloned into pRK-Fc vector. To make Ptpro-Luc, about
2 kb from the transcription initiation site of ptpro was ampliﬁed
by PCR and ligated into pGL3-basic vector.
2.2. Cell culture and transient transfection
HEK293T, L929 and CaCO2 cells were maintained in Dulbecco’s
Modiﬁed Eagle’s Medium (DMEM, Gibco BRL) supplemented with
10% Fetal Bovine Serum (FBS) and antibiotics. For transient trans-
fection experiments, each plasmid DNA was transfected by the cal-
cium phosphate precipitation method. For L929 cells, Welfect-Ex™
was used according to the manufacturer’s instruction (Welgene).
The amount of DNA in each transfection was held constant by
the addition of an appropriate amount of empty expression vector.
2.3. RNA isolation and microarray analysis
Isolation of total RNAs from inducible stable cell lines express-
ing EGFP, Dvl or b-catenin S37A and microarray analysis were per-
formed as described elsewhere [15,16].
2.4. Reverse transcriptase-PCR and real-time PCR analysis
Total RNA was isolated using TRIzoL reagent (Invitrogen)
according to the manufacturer’s protocol. cDNA was synthesized
from total RNA using ImProm-II™ Reverse Transcriptase (Promega)
with random primer. Ampliﬁcation was performed under the fol-
lowing conditions: 94 C for 2 min followed by 30 cycles at 94 C
for 45 s, 58 C for 40 s and 72 C for 40 s. Real-time PCR was carried
out using a PRISM 7000 Sequence Detector (Applied BioSystems)
with SYB GREEN PCRMasterMix (Applied BioSystems). The primers
used were: for b-actin, 50-AGGCCAACCGCGAGAAGATGACC-30
and 50-GAAGTCCAGGGCGACGTAGCAC-30; for Ptpro, 50-GAC-
TCGTTCATCAAACCACC-30 and 50-CTGTGGGCTTCTCTGTCCTA-30.
The threshold cycle (Ct) value for each gene was normalized to
the Ct value for b-actin. The relative mRNA expression was calcu-
lated using the formula: 2DDCt, where DCt = CtPtpro  Ctb-actin and
DDCt = DCtDvl or b-catenin  DCtEGFP.
2.5. Chromatin immunoprecipitation (ChIP) assay
Cells were cross-linked with 1% formaldehyde (Sigma) at room
temperature for 10 min and then incubated with 0.125 M glycine
for 5 min. Re-suspended cells in hypotonic buffer (10 mM Hepes-
KOH, pH 7.8, 10 mM KCl, 1.5 mM MgCl2) were swollen on ice for10 min and then passed through a 26.5 gauge needle 6 times. After
centrifugation at 1000g for 5 min at 4 C, the pellets were incu-
bated with nuclei lysis buffer (1% SDS, 50 mM Tris–HCl, pH 8.0,
10 mM EDTA) for 10 min on ice with occasional vortexing. Chroma-
tin was sheared to an average length size of 0.2–1 kb by sonication
on ice. The appropriate volume of chromatin was diluted to 1/10 in
ChIP dilution buffer (0.01% SDS, 20 mM Tris–HCl, pH 8.0, 167 mM
NaCl, 1.2 mM EDTA, 1.1% Triton X-100), after which preclearing
was performed at 4 C for 2 hwith 10 ll of protein A/G plus-agarose
beads (Santa cruz Biotechnology Lnc). For immunoprecipitation,
goat, rabbit-IgG (Bethyl) and anti-LEF1 (Santa cruz Biotechnology
Lnc, Cell Signaling) were used at 4 C overnight. Immunoprecipi-
tated chromatins were eluted, and reverse cross-linking was
achieved by the addition of 0.3 MNaCl at 65 C overnight. Following
phenol–chloroform extraction and ethanol precipitation, DNA was
dissolved in 50 ll of TE buffer (10 mM Tris–HCl, pH 8.0, 1 mM
EDTA). For PCR, 2 ll of DNA was used.
2.6. Immnunoprecipitation and Western blotting
For immnunoprecipitation, cells were lysed with RIPA buffer
(20 mM Tris–Cl (pH 7.4), 120 mM NaCl, 1% Triton X-100, 0.25%
Na-deoxycholate, 0.05% SDS, 50 mM sodium ﬂuoride, 5 mM EDTA,
0.5 mM sodium orthovanadate, 2 lg/ml of leupeptin, 2 mM PMSF)
After 30 min on ice, the lysate was centrifuged at 12 000g for
10 min, after which the supernatant was collected. Between 300
and 800 lg of lysate was then incubated with anti-Flag M2 or
anti-HA antibodies and Protein A/G Plus-agarose beads (Santa Cruz
Biotechnology Inc.).
Immunoprecipitation under cell-free conditions was performed
as follows. Conditioned media from HEK293T cells transfected
with Wnt1-HA, PTPRO-ECD(1-3)-Fc, mFz8(CRD)-Fc or immuno-
globulin Fc domain (Fc) were collected. As indicated in Fig. 3D,
the conditioned media were mixed overnight and concentrated
using a centricon-20 (Millipore). The concentrated media were
incubated overnight with Protein A/G Plus-agarose beads, which
can recognize and precipitate Fc. Immnoprecipitate was subjected
to SDS–PAGE, and Western blotting was performed using the anti-
bodies indicated in the ﬁgure.
For Western blotting, the following antibodies were used:
monoclonal anti-Flag-M2 antibody from Stratagene, anti-b-catenin
from BD bioscience, anti-HA, anti-a-tubulin monoclonal antibodies
from Santa Cruz Biotechnology. Peroxidase-conjugated goat anti-
mouse and anti-rabbit secondary antibodies (Jackson Lab) and goat
anti-mouse secondary antibody (Santa Cruz Biotechnology, Inc.)
were used, and the proteins were detected using an enhanced
chemiluminescence reagent (ELPIS).
2.7. Crosslinking of proteins using BS3
HEK293T cells were transfected with plasmids as indicated in
Fig. 3C for 24 h. After transfection, the culture media was removed,
followed by washing three times with phosphate buffered saline
(PBS). The cellswere then incubated in PBS containing5 mMBis(sul-
fosuccinimidyl)suberate (BS3), which is a homobifunctional, water-
soluble and membrane-impermeable cross-linker, for 30 min at
room temperature. After removal of the cross-linking solution, cells
were incubated with quenching solution (20 mM Tris–HCl, pH 7.5)
in order to inactivate the residual activity of BS3. Cells were washed
twice with PBS followed by lysis with RIPA buffer for subsequent
experiments.
2.8. Preparation of conditioned media
To obtain conditioned medium (CM) for the cell-free immuno-
precipitation experiments, HEK293T cells were transfected with
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culture medium was exchanged with fresh medium containing
1% FBS and 1% antibiotics. After 36 h incubation, the medium
was collected and used as conditioned medium.
2.9. TOPFLASH luciferase assay
HEK293T cells were transfected with the following plasmids:
0.5 lg of reporter plasmid (pSuperTop), 50 ng of pRL-TK, 0.5 lg
of Fc, mFz(CRD)-Fc, PTPRO(ECD)-Flag or PTPRO-HA. Luciferase
activities were measured 24 h after transfection using a Dual-Lucif-
erase reporter assay kit (Promega).Fig. 2. Tcf/Lef1 is involved in b-catenin mediated induction of ptpro promoter activity. (A)
Arrows in the promoter indicates primers that were used in the ChIP assay. (B) Tcf/Lef1 b
that were isolated from L929 cells treated with MeBIO or BIO (2 lM each for overnigh
sequences were ampliﬁed using primers speciﬁc to the mouse ptpro promoter. (C) Expr
measure the effect of b-catenin(S37A) on the activity of the ptpro promoter, L929 cells w
(Ptpro-Luc), followed by measurement of luciferase activities.
Fig. 1. Identiﬁcation of ptpro as a target gene of Wnt/b-catenin signaling. (A) Schematic
presence of Dox, activated rtTA binds to the bidirectional TRE promoter to induce expr
analysis shows that the expression of ptpro was enhanced by the inducible expression o
2 lM BIO) in mouse ﬁbroblast L929 cell line. Gastrin is a known target gene of Wnt/b-c
ptpro or gastrin. RNAs isolated from mouse ﬁbroblast L929 cell lines inducibly expressin
enhances the level of PTPRO. L929 cells were treated with either NaCl or LiCl (30 mM for
LiCl worked as expected. b-Actin was used as loading control. Asterisk indicates non-sp3. Results
3.1. Expression of ptpro was increased by Wnt/b-catenin signaling
To identify novel target genes of Wnt/b-catenin signaling, we
performed microarray analysis using RNAs isolated from the
mouse ﬁbroblast L929 cell line, which inducibly expressed mouse
Dvl1 (mDvl) or b-cateninS37A (constitutive active form of b-cate-
nin) (Fig. 1A). Microarray analysis suggested ptpro as a candidate
target gene. In the mDvl and b-cateninS37A stable cell line, the
mRNA level of ptpro was signiﬁcantly increased compared to con-
trol cells (Fig. 1B). In addition, the mRNA level was also increasedSchematic diagram showing conserved Tcf/Lef1 binding sites in the ptpro promoter.
inds to the proximal site of the ptpro promoter. Cross-linked chromatin complexes
t) were immunoprecipitated with IgG or anti-Lef1 antibody. Co-precipitated DNA
ession of luciferase under the ptpro promoter was induced by b-catenin(S37A). To
ere transfected with the indicated plasmids in the ﬁgure and a reporter construct
representation of Tet-On inducible system used in our microarray analysis. In the
ession of downstream genes such as EGFP, b-catenin(S37A) or mDvl1. (B) RT-PCR
f mDvl1 or b-catenin(S37A), or by treatment with GSK3b inhibitors (30 mM LiCl or
atenin signaling. GAPDH was used as loading control. (C) Real-time PCR analysis of
g EGFP, mDvl1 or b-catenin(S37A) were used. (D) Treatment of L929 cells with LiCl
24 h) and lysed for Western blotting. The increased level of b-catenin showed that
eciﬁc band and arrow indicates PTPRO.
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(speciﬁc GSK3b inhibitors that activate Wnt/b-catenin signaling)
but not with control NaCl or MeBIO treatment (Fig. 1B, upper pa-
nel). These patterns were very similar to the expression pattern
of gastrin, a well-knownWnt/b-catenin target gene (Fig. 1B, middle
panel). Real-time PCR analysis conﬁrmed that expression of ptpro
was induced by the inducible expression of mDvl and b-cate-
ninS37A (Fig. 1C). Moreover, the protein level of PTPRO was also
increased by treatment of LiCl (Fig. 1D, arrow). Taken together,
these data suggest that ptpro is a novel target gene of Wnt/b-cate-
nin signaling.
3.2. Tcf/Lef1 transcription factor is involved in regulation of the Wnt
mediated induction of ptpro
Since most of the target genes of the Wnt/b-catenin signaling
pathway are mediated by Tcf/Lef1, we investigated whether or
not Tcf/Lef1 transcription factor could bind directly to putative
Tcf/Lef1 binding sites. We identiﬁed three TCF binding sites (50-
A/T A/T CAAAG-30 in Fig. 2A) in the promoter region of mouse
and rat ptpro using the Blat program at UCSC Genome Bioinfor-Fig. 3. PTPRO interacts withWnt via its extracellular domain. (A) Schematic diagram of co
JD, juxtamembrane domain; PTP, protein tyrosine phosphatase domain. Flag or Fc (imm
light gray, respectively. PTPRO(ECD)-Flag or PTPRO-ECD(1-3)-Fc encodes proteins that can
was immunoprecipitated with Wnt3a-HA but not with PTPRO(DEx)-Flag. HEK293T cells
indicated in the ﬁgure. After transfection, lysates were immunoprecipitated with anti-F
linked with PTPRO-Flag, but not with PTPRO(DEx)-Flag. After transfection with the indic
using BS3, followed by immunoprecipitation with anti-Flag antibody and blotting with a
(bottom panel). (D) Extracellular domain of PTPRO interacts with Wnt1 under cell-free co
CM was collected and immunoprecipitated with A/G Plus agarose and then blotted with
PTPRO-ECD(1-3)-Fc in cell lysates were detected with anti-human IgG antibody or anti-H
Fc or PTPRO-ECD(1-3)-Fc.matics Site (http://genome.ucsc.edu/, data not shown). ChIP as-
say was performed to determine whether or not Lef1 binds to
the conserved Tcf/Lef1 binding site of the ptpro promoter. As
shown in Fig. 2B, ChIP with anti-Lef1 antibodies showed a posi-
tive signal. Although treatment of cells with BIO enhanced the
expression of ptpro, it did not change the amount of Lef1 bound
to the promoter (Fig. 2B). This may have been due to activation
of target gene expression caused by Tcf/Lef1 changing its role
from a repressor to an activator via interaction with b-catenin
[6].
To determine whether or not the transcription of ptpro is con-
trolled at the transcriptional level, 2 kb of the putative promoter
region of ptpro was cloned upstream of luciferase cDNA and lucif-
erase assays were performed. Co-transfection of b-cateninS37A en-
hanced ptpro promoter-driven luciferase activity (Fig. 2C). In
addition, this increase was blocked by exogenous expression of
DN-Tcf4 (dominant negative form of Tcf4 that binds to conserved
DNA but cannot interact with b-catenin) in a dose-dependent man-
ner (Fig. 2C). In summary, these data suggest that the level of
PTPRO was regulated at the transcriptional level by the activation
of Tcf/Lef1 transcription factor.nstructs used in this ﬁgure. ECD, extracellular domain; TD, transmembrane domain;
unoglobulin Fc domain) epitope tags at the c-terminal end were marked as black or
be secreted into the media due to lack of a transmembrane domain. (B) PTPRO-Flag
were transfected for 24 h with PTPRO-Flag or PTPRO(DEx)-Flag with Wnt3a-HA as
lag antibody and blotted with the indicated antibodies. (C) Wnt3a-HA was cross-
ated plasmids, PTPRO-Flag and PTPRO(DEx)-Flag were cross-linked with Wnt3a-HA
nti-HA antibody (top panel). Total cell lysates were blotted with anti-HA antibody
nditions. HEK293T cells were transfected with the plasmids indicated in the ﬁgure.
anti-human IgG or anti-HA antibody (right panel). Wnt1-HA, Fc, mFz8(CRD)-Fc or
A antibody (left panel). Asterisks indicate expected sizes of bands for Fc, mFz8(CRD)-
Fig. 4. Negative role for PTPRO in Wnt-mediated reporter activity. (A) Ectopic expression of PTPRO(ECD)-Flag inhibited Wnt-mediated reporter activity. HEK293T cells were
transfected for 24 h with the indicated plasmids in the ﬁgure with reporter constructs (pSuperTopﬂash and pRL-TK). After transfection, luciferase activities were measured.
Luciferase activities were normalized based on the activity of Renilla luciferase (pRL-TK). (B) Reporter constructs were transfected into CaCO2 colorectal cancer cells with
mFz8(CRD)-Fc or PTP-BK-HA, followed by dual luciferase assay.
M. Kim et al. / FEBS Letters 584 (2010) 3923–3928 39273.3. PTPRO is a novel receptor of Wnt
PTPRO is a transmembrane protein that is mainly expressed in
the brain and kidney, and is shown to be involved in axon guidance
[12,17]. Since Wnt is also known to be a morphogen for axon guid-
ance, we examined whether or not PTPRO works as a novel recep-
tor for Wnt. Immunoprecipitation experiments showed that
PTPRO-Flag, but not PTPRO(DEx)-Flag (a deletion construct lacking
an extracellular domain (Fig. 3A)), was co-immunoprecipitated
with HA-tagged Wnt3a (Fig. 3B and C). To determine if this inter-
action occurs at the plasma membrane, a cell membrane non-per-
meable cross-linking chemical, BS3, was used. We assumed that if
Wnt and PTPRO interact with each other at the plasma membrane,
treatment with a cross-linking reagent would cause a mobility
shift during SDS–PAGE. Consistent with our expectation, HA-
Wnt3a, which was detected as a 40 kDa band, was shifted to the
size of PTPRO (about 220 kDa) after cross-linking (compare lanes
3 and 4 in Fig. 3C). When total cell lysates were examined, we also
detected a modest shift for Wnt3a-HA after cross-linking in
PTPRO(DEx)-Flag transfected cells (lane 8 of the lower panel in
Fig. 3C). This shift might have been caused by interaction with
endogenous receptor proteins such as Frizzled, LRP6 or PTPRO,
since immunoprecipitation with anti-Flag antibody in lysates of
PTPRO(DEx)-Flag transfected cells did not produce any signal
indicative of Wnt3a-HA (upper panel in Fig. 3C). Overall, these re-
sults suggest that Wnt3a interacted with PTPRO at the plasma
membrane.
To eliminate the possibility that the interaction between PTPRO
andWnt3awas an artifact caused by overexpression, we performed
immunoprecipitation under cell-free conditions. Conditioned med-
ia collected from the culture media of HEK293T cells transfected
withWnt1-HA or PTPRO-ECD(1-3)-Fc (a construct containing three
extracellular FN3-like domains each fusedwith Fc) were used, since
these proteins were secreted more thanWnt3a-HA or PTPRO(ECD)-
Flag, respectively. The conditioned media indicated in Fig. 3D were
mixed and immunoprecipitated with A/G Plus agarose, followed by
Western blotting with either anti-human IgG or anti-HA antibodies
(Fig. 3D). mFz8(CRD)-Fc, which contains a cyteine rich domain of
mouse Frizzled8 that interactswithWnt,was used as a positive con-
trol. Both mFz8(CRD)-Fc and PTPRO-ECD(1-3)-Fc strongly inter-
acted with Wnt1-HA, but Fc that was used as a negative control
did not (Fig. 3A and D). To conﬁrm the interaction between Wnt
and PTPRO, we tested whether or not the ectopic expression of
PTPRO(ECD)-Flag inhibits Wnt-mediated reporter activity, similar
to how ectopic expression of mFz8(CRD)-Fc inhibits Wnt/b-catenin
signaling by preventing Wnt from interacting with Frizzled [18](Fig. 4). Ectopic expression of PTPRO(ECD)-Flag inhibitedWnt-med-
iated reporter activity while Fc did not. Overall, these results sug-
gest that Wnt bound to the extracellular domain of PTPRO, which
served as a novel receptor of Wnt.
Next, we examined whether or not the ectopic expression of
full-length PTPRO has any effect on Wnt signaling. When plasmid
encoding PTPRO-HA was transfected with reporter plasmids into
CaCO2 colorectal cancer cells, within which most Wnt proteins
are expressed and autocrine Wnt/b-catenin signaling can be
blocked by the expression of secreted frizzled-related proteins
(SFRPs) [19], the reporter activity was signiﬁcantly reduced similar
to the expression of mFz8(CRD)-Fc (Fig. 4D). This result suggests
that the increased level of PTPRO due to Wnt signaling may play
a role in negative feedback.
4. Discussion
In this report, we present evidence that PTPRO is a new target of
the Wnt signaling pathway. We showed that the levels of both the
mRNA and protein of ptpro were increased by Wnt/b-catenin sig-
naling. Consistent with this ﬁnding, it has been shown that the
expression of ptpro is reduced 12-fold in the kidney of Wnt4
knockout mice [20]. In addition, ChIP and reporter assays sug-
gested that the increased expression of ptpro was mediated by
Tcf/Lef1. Interestingly, we found that PTPRO interacted with Wnt
via its extracellular domain and that ectopic expression of PTPRO
inhibited autocrineWnt/b-catenin signaling in CaCO2 cells. Overall,
these data strongly suggest that Wnt bound to PTPRO at the plas-
ma membrane where it serves as a novel receptor for Wnt
signaling.
Since hypermethylation at the promoter of ptpro in human lung
cancer leads to reduced expression of ptpro, PTPRO is thought as a
tumor suppressor protein [21]. Consistent with this ﬁnding, it has
been shown that the expression of mir 17–92 cluster, which tar-
gets the 30 UTR of ptpro, is increased in human lung cancer cells,
which leads to reduction of PTPRO [22,23]. The reduction of Wnt
reporter activity by ectopic expression of PTPRO in CaCO2 cells
(Fig. 4B) seems to be consistent with previous ﬁndings. Therefore,
our data suggest that PTPRO may act as a tumor suppressor by
blocking autocrine Wnt signaling.
No ligands of receptor type protein tyrosine phosphatase (RPTP)
have been found thus far, besides the fact that pleiotrophin is a li-
gand of RPTPb/f [24]. Although we could not identify any sub-
strates of activated PTPRO, we provided evidence that Wnt was a
ligand for PTPRO and that PTPROmay have inhibitedWnt signaling
(Fig 3). PTPRO may inhibit Wnt signaling not only by sequestration
3928 M. Kim et al. / FEBS Letters 584 (2010) 3923–3928of Wnt ligand but also by regulation of other Wnt signaling compo-
nents. For example, Drosophila homolog of PTPRO, ptp4e or ptp10d,
plays an inhibitory role in EGF signaling by genetically interacting
with epidermal growth factor receptor (EGFR) [25]. It may be pos-
sible that activation of PTPRO by binding with Wnt regulates EGF
signaling as well. Therefore, identiﬁcation of substrate(s) that spe-
ciﬁcally interact with PTPRO upon binding of Wnt will allow us to
mine novel signaling pathway(s) that can crosstalk with Wnt
signaling.Acknowledgements
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